OLMA
Olema Pharmaceuticals Inc
NASDAQ: OLMA · HEALTHCARE · BIOTECHNOLOGY
$14.41
+1.91% today
Updated 2026-04-30
Market cap
$1.23B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$4 – $36
Volume
1.6M
Olema Pharmaceuticals Inc (OLMA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $3.27M | $132000.00 | $342.72M | $295.94M | $215.65M | $276.94M | $450.98M |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $3.24M | $103000.00 | $342.14M | $290.69M | $208.90M | $266.51M | $438.47M |
| Total liabilities | $9.55M | $10.73M | $4.58M | $11.38M | $18.10M | $23.05M | $42.02M |
| Current liabilities | $201000.00 | $1.38M | $4.58M | $9.02M | $16.55M | $21.62M | $41.76M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | $-6.45M | $-10.76M | $-33.09M | $-104.19M | $-208.98M | $-305.63M | $-435.11M |
| Accounts receivable | — | — | — | $130000.00 | $319000.00 | $673000.00 | $2.12M |
| Inventory | — | — | — | $-353000.00 | $-319000.00 | — | $-4.02M |
| Goodwill | — | — | — | — | — | — | — |